Ixinity is a Kit in the Human Prescription Drug category. It is labeled and distributed by Aptevo Biotherapeutics Llc. The primary component is .
Product ID | 70504-0288_3e70e9c6-6f1f-4d70-ac2b-3f3c6d427d00 |
NDC | 70504-0288 |
Product Type | Human Prescription Drug |
Proprietary Name | Ixinity |
Generic Name | Coagulation Factor Ix (recombinant) |
Dosage Form | Kit |
Marketing Start Date | 2017-05-12 |
Marketing Category | BLA / BLA |
Application Number | BLA125426 |
Labeler Name | Aptevo BioTherapeutics LLC |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-05-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125426 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-05-12 |
SPL SET ID: | 9521898c-61aa-44ab-8ab8-84274ca19943 |
Manufacturer | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
70504-0284 | Ixinity | Ixinity |
70504-0287 | Ixinity | Ixinity |
70504-0288 | Ixinity | Ixinity |
70504-0283 | Ixinity | Ixinity |
70504-0289 | Ixinity | Ixinity |
70504-0282 | Ixinity | Ixinity |
58394-633 | BeneFIX | coagulation factor ix (recombinant) |
58394-634 | BeneFIX | coagulation factor ix (recombinant) |
58394-635 | BeneFIX | coagulation factor ix (recombinant) |
0944-3026 | RIXUBIS | COAGULATION FACTOR IX (RECOMBINANT) |
0944-3028 | RIXUBIS | COAGULATION FACTOR IX (RECOMBINANT) |
0944-3030 | RIXUBIS | COAGULATION FACTOR IX (RECOMBINANT) |
0944-3032 | RIXUBIS | COAGULATION FACTOR IX (RECOMBINANT) |
0944-3034 | RIXUBIS | COAGULATION FACTOR IX (RECOMBINANT) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
IXINITY 97308301 not registered Live/Pending |
APTEVO BIOTHERAPEUTICS LLC 2022-03-11 |
IXINITY 86322323 4788624 Live/Registered |
APTEVO BIOTHERAPEUTICS LLC 2014-06-27 |
IXINITY 85220714 4597459 Live/Registered |
APTEVO BIOTHERAPEUTICS LLC 2011-01-19 |